A monoclinic crystal form of a nitroethylenyl biphenyl compound, and methods of making and using the same
By preparing the monoclinic crystal form of 4-(2-nitrovinyl)-1,1′-biphenyl compound in a specific solvent, the problem of crystal form instability was solved, enabling more efficient application of antibacterial drugs and the effects of cell quorum sensing modulators.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- GUIZHOU UNIV
- Filing Date
- 2023-12-06
- Publication Date
- 2026-06-26
AI Technical Summary
In the prior art, the crystal form of 4-(2-nitrovinyl)-1,1′-biphenyl compounds is unstable, resulting in low bioavailability as antibacterial drugs and cell quorum sensing regulators.
Monoclinic crystal forms of 4-(2-nitrovinyl)-1,1′-biphenyl compounds were prepared in specific solvents using gas-phase diffusion, liquid-phase diffusion, and vacuum sublimation methods. By controlling the cell parameters and molecular arrangement, stable monoclinic crystal forms were formed.
The prepared monoclinic crystal form has good physical and chemical properties, is suitable for antibacterial drugs, improves bioavailability, and is easy to industrialize.
Smart Images

Figure BDA0004595343750000051 
Figure BDA0004595343750000064 
Figure BDA0004595343750000071